organophosphonates has been researched along with pentostatin in 2 studies
Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (pentostatin) | Trials (pentostatin) | Recent Studies (post-2010) (pentostatin) |
---|---|---|---|---|---|
9,968 | 880 | 3,596 | 1,009 | 102 | 119 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arteaga, CL; Brown, TD; Craig, JB; Harman, GS; Havlin, KA; Koeller, JM; Kuhn, JG; Von Hoff, DD; Weiss, GR | 1 |
Balzarini, J; De Clercq, E; Hatse, S; Naesens, L | 1 |
1 review(s) available for organophosphonates and pentostatin
Article | Year |
---|---|
New anticancer agents.
Topics: Adenine; Antibiotics, Antineoplastic; Antineoplastic Agents; Biphenyl Compounds; Depsipeptides; Echinomycin; Epirubicin; Flavonoids; Guanidines; Humans; Idarubicin; Imides; Isoquinolines; Menogaril; Naphthalimides; Nogalamycin; Organophosphonates; Pentostatin; Peptides, Cyclic; Polymers; Vidarabine Phosphate | 1988 |
1 other study(ies) available for organophosphonates and pentostatin
Article | Year |
---|---|
N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties.
Topics: Adenine; Adenosine Deaminase; Adenosine Triphosphate; AMP Deaminase; Animals; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cell Division; Deoxyadenine Nucleotides; Drug Interactions; Drug Screening Assays, Antitumor; Erythrocytes; Guanine; Humans; K562 Cells; Leukemia L1210; Mice; Organophosphonates; Organophosphorus Compounds; Pentostatin; Prodrugs; Rats; Tumor Cells, Cultured | 1999 |